SYDNEY, Jan. 31, 2019 /PRNewswire/ -- The iQ Group Global, a consortium of life science and financial services companies which span the biopharma value chain from asset discovery to commercialization, ...
Bulletin: ...WINTER WEATHER ADVISORY REMAINS IN EFFECT UNTIL 1 PM EST THIS AFTERNOON... * WHAT...Snow. Total snow accumulations between 3 and 5 inches. * WHERE ...
SYDNEY, Oct. 19, 2021 /PRNewswire/ -- The iQ Group Global Ltd (NSX.IQG), on behalf of its subsidiary, Life Science Biosensor Diagnostics Pty Ltd (LSBD), is pleased to announce that one of its ...
Harvard University’s Wyss Institute for Biologically Inspired Engineering licensed its Erapid electrochemical sensing platform to IQ Group Global to integrate with the Australian consortium’s ...
The Wyss Institute for Biologically Inspired Engineering at Harvard University and GBS Inc., a subsidiary of The iQ Group Global, announce that they will collaborate to validate and de-risk a specific ...
Combination of the Wyss' electrochemical sensing technology with GBS's transistor technology could enable fast, multiplexed, low-cost COVID-19 biomarker analysis in point-of-care applications. (BOSTON ...
An Australia-based biotechnology company has acquired an anti-cancer drug platform developed by University of Texas researchers, the company said Monday. IQ Global, which specializes in finding and ...
The low-cost multiplexed electrochemical biomarker detection platform will be commercialized in point-of-care diagnostics to be put into the hands of patients and primary health practitioners “After ...
Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback